Federated Hermes
PMVP icon

Federated Hermes’s PMV Pharmaceuticals PMVP Stock Holding History

Federated Hermes’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,034
Closed -$6.09K – 2173
2024
Q4 		$6.09K Sell
4,034
-4,210
-51% -$6.67K ﹤0.01% 1880
2024
Q3 		$12.3K Buy
8,244
+4,361
+112% +$6.74K ﹤0.01% 1794
2024
Q2 		$6.29K Buy
3,883
+259
+7% +$467 ﹤0.01% 1818
2024
Q1 		$6.16K Sell
3,624
-699,714
-99% -$1.31M ﹤0.01% 1818
2023
Q4 		$2.18M Sell
703,338
-80,201
-10% -$212K 0.01% 925
2023
Q3 		$4.81M Sell
783,539
-57,277
-7% -$394K 0.01% 703
2023
Q2 		$5.26M Buy
840,816
+342,553
+69% +$1.8M 0.01% 679
2023
Q1 		$2.38M Buy
498,263
+432,674
+660% +$3.04M 0.01% 902
2022
Q4 		$571K Sell
65,589
-184,411
-74% -$1.97M ﹤0.01% 1326
2022
Q3 		$2.98M Sell
250,000
-94
-0% -$1.36K 0.01% 796
2022
Q2 		$3.56M Sell
250,094
-131,882
-35% -$1.92M 0.01% 774
2022
Q1 		$7.95M Buy
381,976
+69,955
+22% +$1.23M 0.02% 664
2021
Q4 		$7.21M Buy
312,021
+62,021
+25% +$1.5M 0.01% 738
2021
Q3 		$7.45M Hold
250,000
– – 0.01% 724
2021
Q2 		$8.54M Hold
250,000
– – 0.02% 710
2021
Q1 		$8.22M Hold
250,000
– – 0.02% 723
2020
Q4 		$15.4M Hold
250,000
– – 0.03% 533
2020
Q3 		$8.88M Buy
+250,000
New +$9.2M 0.02% 595

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes's PMVP Position: Q1 2025 in Review

Federated Hermes sold out of PMV Pharmaceuticals (PMVP) in Q1 2025, closing a stake of 4,034 shares — an estimated $6.09K sold.

Federated Hermes first reported a position in PMVP in Q3 2020 and held it in 18 quarters. The position peaked at $15.4M in Q4 2020. 55 funds tracked by Wall St. Rank hold PMVP as of Q1 2025.

  • Federated Hermes reported no remaining PMV Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Federated Hermes sold 4,034 PMV Pharmaceuticals shares in Q1 2025, an estimated $6.09K.
  • Federated Hermes first reported a position in PMV Pharmaceuticals in Q3 2020 and held it in 18 quarters.
  • Federated Hermes's PMV Pharmaceuticals position peaked at $15.4M in Q4 2020.
  • 55 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2025.

Based on Federated Hermes's 13F filing for Q1 2025, filed 8 May 2025.